Seshu Tyagarajan, Ph.D., RAC
Chief Technical and Development OfficeratCandel Therapeutics· In the 2024 proxy
Seshu Tyagarajan, Ph.D., RAC is Chief Technical and Development Officer of Candel Therapeutics.
Experience
- Candel TherapeuticsPublic company · 2 yr
- Chief Technical and Development Officer2024 – Present · 2 yrStock in role +661%
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?